Cortical excitability decreases in Lennox-Gastaut syndrome

Epilepsia

Volumn 53, Issue 9, 2012, Pages 1546-1553

  Badawy, Radwa A B ^a,b   MacDonell, Richard A L ^c   Vogrin, Simon J ^a   Lai, Alan ^d   Cook, Mark J ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c AUSTIN HOSPITAL   (Australia)

^d BIONICS INSTITUTE   (Australia)

Author keywords

Cortical excitability; Epilepsy; Lennox Gastaut syndrome; Transcranial magnetic stimulation

Indexed keywords

ADULT; ARTICLE; BRAIN CORTEX; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENERALIZED EPILEPSY; HUMAN; LENNOX GASTAUT SYNDROME; MALE; MOTOR PERFORMANCE; NEUROMUSCULAR FACILITATION; NEUROMUSCULAR FUNCTION; PRIORITY JOURNAL; SEIZURE THRESHOLD; TRANSCRANIAL MAGNETIC STIMULATION;

ADOLESCENT; ADULT; COHORT STUDIES; EVOKED POTENTIALS, MOTOR; FEMALE; HUMANS; INTELLECTUAL DISABILITY; MALE; MOTOR CORTEX; SPASMS, INFANTILE; TRANSCRANIAL MAGNETIC STIMULATION; YOUNG ADULT;

EID: 84866117702     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2012.03599.x     Document Type: Article

References (46)

1. Aicardi J,. (1994) Syndromic classification in the management of childhood epilepsy. J Child Neurol 9 (Suppl. 2): 14-18.
2. Akgun Y, Soysal A, Atakli D, Yuksel B, Dayan C, Arpaci B,. (2009) Cortical excitability in juvenile myoclonic epileptic patients and their asymptomatic siblings: a transcranial magnetic stimulation study. Seizure 18: 387-391.
3. Arzimanoglou A, French J, Blume WT, Cross JH, Ernst JP, Feucht M, Genton P, Guerrini R, Kluger G, Pellock JM, Perucca E, Wheless JW,. (2009) Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol 8: 82-93.
4. Badawy RA, Curatolo JM, Newton M, Berkovic SF, Macdonell RA,. (2007) Changes in cortical excitability differentiate generalized and focal epilepsy. Ann Neurol 61: 324-331.
5. Badawy RA, Macdonell RA, Jackson GD, Berkovic SF,. (2010) Can changes in cortical excitability distinguish progressive from juvenile myoclonic epilepsy? Epilepsia 51: 2084-2088.
6. Blume WT,. (2001) Pathogenesis of Lennox-Gastaut syndrome: considerations and hypotheses. Epileptic Disord 3: 183-196.
7. Boroojerdi B,. (2002) Pharmacologic influences on TMS effects. J Clin Neurophysiol 19: 255-271.
8. Cantello R, Civardi C, Cavalli A, Varrasi C, Tarletti R, Monaco F, Migliaretti G,. (2000) Cortical excitability in cryptogenic localization-related epilepsy: interictal transcranial magnetic stimulation studies. Epilepsia 41: 694-704.
9. Caramia MD, Gigli G, Iani C, Desiato MT, Diomedi M, Palmieri MG, Bernardi G,. (1996) Distinguishing forms of generalized epilepsy using magnetic brain stimulation. Electroencephalogr Clin Neurophysiol 98: 14-19.
10. Chugani HT, Mazziotta JC, Engel J Jr, Phelps ME,. (1987) The Lennox-Gastaut syndrome: metabolic subtypes determined by 2-deoxy-2[18F]fluoro- d-glucose positron emission tomography. Ann Neurol 21: 4-13.
11. Cicinelli P, Mattia D, Spanedda F, Traversa R, Marciani MG, Pasqualetti P, Rossini PM, Bernardi G,. (2000) Transcranial magnetic stimulation reveals an interhemispheric asymmetry of cortical inhibition in focal epilepsy. NeuroReport 11: 701-707.
12. Cohen JB,. (1969) Statistical power analysis for the behavioral sciences. Academic Press, New York.
13. Crumrine PK,. (2002) Lennox-Gastaut syndrome. J Child Neurol 17 (Suppl. 1): S70-S75.
14. Danner N, Julkunen P, Khyuppenen J, Hukkanen T, Kononen M, Saisanen L, Koskenkorva P, Vanninen R, Lehesjoki AE, Kalviainen R, Mervaala E,. (2009) Altered cortical inhibition in Unverricht-Lundborg type progressive myoclonus epilepsy (EPM1). Epilepsy Res 85: 81-88.
15. Di Lazzaro V, Restuccia D, Oliviero A, Profice P, Ferrara L, Insola A, Mazzone P, Tonali P, Rothwell JC,. (1998) Magnetic transcranial stimulation at intensities below active motor threshold activates intracortical inhibitory circuits. Exp Brain Res 119: 265-268.
16. Di Lazzaro V, Oliviero A, Pilato F, Saturno E, Dileone M, Meglio M, Colicchio G, Barba C, Papacci F, Tonali PA,. (2004) Effects of vagus nerve stimulation on cortical excitability in epileptic patients. Neurology 62: 2310-2312.
17. Fedi M, Berkovic SF, Macdonell RA, Curatolo JM, Marini C, Reutens DC,. (2008) Intracortical hyperexcitability in humans with a GABAA receptor mutation. Cereb Cortex 18: 664-669.
18. Florian J, Muller-Dahlhaus M, Liu Y, Ziemann U,. (2008) Inhibitory circuits and the nature of their interactions in the human motor cortex a pharmacological TMS study. J Physiol 586: 495-514.
19. Hamer HM, Reis J, Mueller HH, Knake S, Overhof M, Oertel WH, Rosenow F,. (2005) Motor cortex excitability in focal epilepsies not including the primary motor area-a TMS study. Brain 128: 811-818.
20. Iinuma K, Yanai K, Yanagisawa T, Fueki N, Tada K, Ito M, Matsuzawa T, Ido T,. (1987) Cerebral glucose metabolism in five patients with Lennox-Gastaut syndrome. Pediatr Neurol 3: 12-18.
21. Joo EY, Hong SB, Han HJ, Tae WS, Kim JH, Han SJ, Seo DW, Lee KH, Hong SC, Lee M, Kim S, Kim BT,. (2005) Postoperative alteration of cerebral glucose metabolism in mesial temporal lobe epilepsy. Brain 128: 1802-1810.
22. Kaiser LG, Schuff N, Cashdollar N, Weiner MW,. (2005) Age-related glutamate and glutamine concentration changes in normal human brain: 1H MR spectroscopy study at 4T. Neurobiol Aging 26: 665-672.
23. Knorle R, Assmann D, Landwehrmeyer GB, Scheremet R, Muller K, Feuerstein TJ,. (1997) Aspartate, glutamate, glutamine, glycine and gamma-aminobutyric acid in human bioptic neocortical areas: comparison to autoptic tissue. Neurosci Lett 221: 169-172.
24. Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Ferbert A, Wroe S, Asselman P, Marsden CD,. (1993) Corticocortical inhibition in human motor cortex. J Physiol 471: 501-519.
25. Kwan P, Brodie MJ,. (2000) Early identification of refractory epilepsy. N Engl J Med 342: 314-319.
26. Manganotti P, Bongiovanni LG, Zanette G, Fiaschi A,. (2000) Early and late intracortical inhibition in juvenile myoclonic epilepsy. Epilepsia 41: 1129-1138.
27. Manganotti P, Tamburin S, Zanette G, Fiaschi A,. (2001) Hyperexcitable cortical responses in progressive myoclonic epilepsy: a TMS study. Neurology 57: 1793-1799.
28. Manganotti P, Tamburin S, Bongiovanni LG, Zanette G, Fiaschi A,. (2004) Motor responses to afferent stimulation in juvenile myoclonic epilepsy. Epilepsia 45: 77-80.
29. Manganotti P, Bongiovanni LG, Fuggetta G, Zanette G, Fiaschi A,. (2006) Effects of sleep deprivation on cortical excitability in patients affected by juvenile myoclonic epilepsy: a combined transcranial magnetic stimulation and EEG study. J Neurol Neurosurg Psychiatry 77: 56-60.
30. Markand ON,. (2003) Lennox-Gastaut syndrome (childhood epileptic encephalopathy). J Clin Neurophysiol 20: 426-441.
31. Mavroudakis N, Caroyer JM, Brunko E, Zegers de Beyl D,. (1997) Effects of vigabatrin on motor potentials evoked with magnetic stimulation. Electroencephalogr Clin Neurophysiol 105: 124-127.
32. McDonnell MN, Orekhov Y, Ziemann U,. (2007) Suppression of LTP-like plasticity in human motor cortex by the GABAB receptor agonist baclofen. Exp Brain Res 180: 181-186.
33. Molnar GF, Sailer A, Gunraj CA, Cunic DI, Wennberg RA, Lozano AM, Chen R,. (2006) Changes in motor cortex excitability with stimulation of anterior thalamus in epilepsy. Neurology 66: 566-571.
34. Mott DD, Lewis DV,. (1994) The pharmacology and function of central GABAB receptors. Int Rev Neurobiol 36: 97-223.
35. Nabbout R, Dulac O,. (2003) Epileptic encephalopathies: a brief overview. J Clin Neurophysiol 20: 393-397.
36. Nelissen N, Van Paesschen W, Baete K, Van Laere K, Palmini A, Van Billoen H, Dupont P,. (2006) Correlations of interictal FDG-PET metabolism and ictal SPECT perfusion changes in human temporal lobe epilepsy with hippocampal sclerosis. Neuroimage 32: 684-695.
37. Oldfield RC,. (1971) The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9: 97-113.
38. Reutens DC, Berkovic SF,. (1992) Increased cortical excitability in generalised epilepsy demonstrated with transcranial magnetic stimulation. Lancet 339: 362-363.
39. Rossini PM, Rossi S,. (2007) Transcranial magnetic stimulation: diagnostic, therapeutic, and research potential. Neurology 68: 484-488.
40. Rossini PM, Barker AT, Berardelli A, Caramia MD, Caruso G, Cracco RQ, Dimitrijević MR, Hallett M, Katayama Y, Lücking CH,. (1994) Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroencephalogr Clin Neurophysiol 91: 79-92.
41. Rothwell JC,. (1997) Techniques and mechanisms of action of transcranial stimulation of the human motor cortex. J Neurosci Methods 74: 113-122.
42. Sundaram SK, Chugani HT, Chugani DC,. (2005) Positron emission tomography methods with potential for increased understanding of mental retardation and developmental disabilities. Ment Retard Dev Disabil Res Rev 11: 325-330.
43. Theodore WH, Rose D, Patronas N, Sato S, Holmes M, Bairamian D, Porter RJ, Di Chiro G, Larson S, Fishbein D,. (1987) Cerebral glucose metabolism in the Lennox-Gastaut syndrome. Ann Neurol 21: 14-21.
44. Werhahn KJ, Lieber J, Classen J, Noachtar S,. (2000) Motor cortex excitability in patients with focal epilepsy. Epilepsy Res 41: 179-189.
45. Ziemann U,. (2003) Pharmacology of TMS. Suppl Clin Neurophysiol 56: 226-231.
46. Ziemann U,. (2004) TMS and drugs. Clin Neurophysiol 115: 1717-1729.